3
Announcements
Trials
Browse
Landscape
Status
Recruiting
7
Active not recruiting
7
Terminated
6
Completed
4
Unknown
2
Withdrawn
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Gastrointestinal
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
Cyclophosphamide
32
Rituximab
24
zanubrutinib
19
Vincristine
16
fludarabine
14
Prednisone
14
Magnetic Resonance Spectroscopy
14
venetoclax
13
blinatumomab
13
Specimen Handling
13
Doxorubicin
13
Bendamustine Hydrochloride
11
obinutuzumab
10
Lenalidomide
9
Dexamethasone
9
polatuzumab vedotin
8
Methotrexate
8
Biopsy
8
glofitamab
7
Prednisolone
7
Cytarabine
7
Radiotherapy
6
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
6
pirtobrutinib
5
pegaspargase
5
Immunotherapy, Adoptive
5
tislelizumab
4
tafasitamab
4
selinexor
4
orelabrutinib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
ponatinib
×
Lymphoid
×
Clear all
NCT06175702
2023-12-19
LALPh2022
PETHEMA Foundation
Not yet recruiting
150 enrolled